Navigation Links
Cerimon Pharmaceuticals Initiates Phase I Clinical Study of Topical Diclofenac Sodium Patch
Date:10/2/2007

Diclofenac Patch is Second Cerimon Product Candidate to Enter Clinical

Studies in 2007

SOUTH SAN FRANCISCO, Oct. 2 /PRNewswire/ -- Cerimon Pharmaceuticals, Inc., announced today it has initiated a Phase I clinical study of a novel diclofenac sodium patch, the Company's lead pain asset. The study will evaluate safety, tolerability, and systemic pharmacokinetics of a topical patch formulation of diclofenac sodium, a non-steroidal anti-inflammatory drug (NSAID), in 16 healthy volunteers. The Phase I study is expected to be completed in the fourth quarter of 2007. Following the completion of this study, Cerimon plans to rapidly initiate late-stage efficacy and safety studies of its diclofenac sodium patch in patients with acute musculoskeletal pain.

"Topical diclofenac is the second therapeutic product Cerimon has advanced into clinical studies this year, following the initiation of Phase IIb testing for Simulect(R) (basiliximab) in the first quarter," stated Paul Sekhri, President and CEO of Cerimon Pharmaceuticals. "We are proud of this progress and believe the diclofenac patch will address the market need for safe and effective topical pain therapies. Currently, topical NSAIDs are marketed in Europe, Japan, and other parts of the world, but not in the U.S. Their advantage in treating musculoskeletal pain is the ability to deliver drug directly to the affected area with minimal systemic exposure. Given the systemic side effects of traditional non-topical NSAIDs, as well as the withdrawal of some COX-2 inhibitors, we believe developing a new treatment option is an important goal for the medical community."

Pain Market

Musculoskeletal pain is pain that affects the muscles, ligaments, and tendons. Acute musculoskeletal injuries are common and can occur during sports activities, exercise, or other physical activities. They often result in pain due to soft tissue injuries, such as sprains, strains, and minor co
'/>"/>

SOURCE Cerimon Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...,Nov.25/PRNewswire/--Reportlinker.comannouncesthat... ,, UnitedStatesDentalDevicesMarketAnalysisand...m/p0158733/United-States-Dental-Devices-Market-Ana...esDentalDevicesMarketAnalysisandForecaststo2015 ,...orin-depthinformationanddatarelatingtotheUSdentald...
(Date:11/25/2009)...,Mass.,Nov.25/PRNewswire/--AccordingtoMillenniumRe...logymarketintelligence,thenearly$3billionUSmarketf...hoverthenextfiveyearsdespitetherecenteconomicslowd...ndsthatthismarketwillremainhighlydynamicoverthenex...vicesinpreviouslyunderservedsegmentsofthetraumafix...
(Date:11/25/2009)...,Nov.25/PRNewswire/--Reportlinker.comannouncesthat... ,, IntranasalDrugDelivery-USMarketTrends&...ranasal-Drug-Delivery---US-Market-Trends--Analysis...tnessinganexpansionoftherapeuticapplicationsfromth...eliveryofsystemictherapeuticdrugs.Thefutureofthete...
Breaking Medicine Technology:Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Principle Pharmacy Group Inc Announces Founders Retirement New CEO Officers and Appointments to Its Board of Directors 48313 1UNC scientists identify growth factor as possible cancer drug target 48310 1Web of Science 28R 29 Renewals Remain Strong Despite Tough Economic Climate 12544 1Web of Science 28R 29 Renewals Remain Strong Despite Tough Economic Climate 12544 2
...Five years after the identification of,the gene re...elerated and,premature ageing, a team of Spanish a... - University of Oviedo - and Nicolas Levy and col...fully demonstrated a treatment,for the disease, us...harmacological molecules, should slow down the pro...
...DELPHIA, June 30 ,GlaxoSmithKline (NYSE: GSK ) to...plication to the U.S. Food and Drug Administration... prevent cervical cancer., GSK has submitted its ...omplete Response Letter, received in December, 200...hase III pivotal efficacy study, HPV-008, are,expe...
Other Medicine Technology:Hope for Progeria - Successfully Validated on Mice, a Treatment Could Soon be Tested on Children 2GlaxoSmithKline Responds to FDA on CERVARIX(R) and Plans to Submit Final Study Data for Approval 2GlaxoSmithKline Responds to FDA on CERVARIX(R) and Plans to Submit Final Study Data for Approval 3
(Date:11/25/2009)...e/--TheBartleHallConventionCenterwilltemporarilybe...KansasCityhoststhelatestinaseriesofmassivefreeclin...asthepotentialtobethebiggestoneyet,becauseitwillex...insteadofoveraweekend,"SheriWood,executivedirector...tionalAssociationofFreeClinics(NAFC). ,, Atprev...
(Date:11/25/2009)...inelleMedicalInc.,aleadingmanufacturerofbreastMRIc...ofnewleadingedgeclinicalapplicationsonitsAegis(TM)...icalSocietyofNorthAmerica(RSNA)annualmeetinginChic...ionsleveragetheuniquehighqualityimagesgeneratedbyS...tipleimagingmodalitiesformulti-parametricassessmen...
(Date:11/25/2009)...Newswire/--TheBlackAIDSInstituterecentlyheldBoardo...r2010. ,, ThenewBoardMembersareahighlydiversegr...nce,governmenthealthprograms,editorial,andbusiness...personalbackgroundsincludingbothheterosexualandgay...presentingmultipleagegroups. ,, (Photo: http://...
(Date:11/25/2009)...cer who were treated with cisplatin-based chemothe...logical side effects and Raynaud-like phenomena, t...cording to a new study published online November 2... . , Marianne Brydy, M.D., of the Department of ..., Norway, and colleagues conducted a cross-section...
(Date:11/25/2009)... This simple question has been the focus of intens...e Modulates High Blood Pressure in Mice & Men, Do...estion has been the focus of intense research for ...me established a link between a novel gene, phosdu...mice as well as humans. The studies were directed ...
Breaking Medicine News(10 mins):Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:New stress-related gene modulates high blood pressure in mice and men 2
...ican Chemical Society in Washington will focus on ...agents through a sealed envelope and detect tumors...ng the door to a wide variety of // applications a...nd microwave radiation. The waves have alread...
...es have said that it is possible to help children ...pplement of zinc. The research report was publishe...From 2000 to 2003, pneumonia caused 2 million of 1...of zinc have been reported to prevent acute lower ...
...est edition of The Lancet had found the drug artes...ia than the common drug quinine. Quinine is t...evere malaria throughout Africa, South America, an... more rapidly acting, in terms of parasite clearan...
...ber one killer in adults. TB is a lung disease, ca...on is infected with TB somewhere in the world ever...termed BCG is currently available which, however, ...on the rise, which cannot be treated by first-line...
...s declared Tuberculosis as an emergency in Africa....ry year. WHO Regional // Committee for Africa comp...declared tuberculosis an emergency in the African ...puto, Mozambique. The resolution wishes Member Sta...
...stitute had discovered a new molecular explanation...ed behavior in the disease called porphyria, the d...king George III. The Dana-Farber scientists ...abolic molecule, PGC-1 alpha, in cells of the live...
Other Medicine News:Health News:WHO declares Tuberculosis – ‘An Emergency’ in Afr 2Health News:Study Unveils New Insight To The Madness Of King George III 2
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
Medicine Products: